New drug - Relistor
Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more
Guidelines
, or Show all guidelines.
- Acupuncture
- Acute Coronary Syndrome: Clopidogrel (NICE)
- Acute Coronary Syndromes: Glycoprotein IIb/IIIa Inhibitors (NICE)
- ADHD: Methylphenidate, Atomoxetine, Dexamfetamine (NICE)
- Alzheimer's Disease: Donepezil, Galantamine, Rivastigmine, Memantine (NICE)
- Anaemia, Cancer Treatment-Induced: Epoetin Alfa, Epoetin Beta, Darbepoetin (NICE)
- Ankylosing Spondylitis: Adalimumab, Etanercept, Infliximab (NICE)
- Antihypertensive Drugs, Effectiveness in Black People
- Asthma and COPD, Inhaler Devices for Management of
- Asthma Management: BTS/SIGN Guidelines
- Asthma, Chronic: Use of Inhaled Corticosteroids in Adults and Children >12 Years (NICE)
- Asthma, Chronic: Use of Inhaled Corticosteroids in Children <12 Years (NICE)
- Asthma, Chronic: Use of Inhaler Devices in Children 5-15 Years (NICE)
- Asthma, Chronic: Use of Inhaler Systems (Devices) in Children <5 Years (NICE)
- Asthma, Severe Persistent Allergic: Omalizumab (NICE)
- Back Pain (Low), Acute and Chronic
- Breast Disorders: Management of
- Breastfeeding, Promoting the Initiation of
- Cancer, Brain (Recurrent Malignant Glioma): Temozolomide (NICE)
- Cancer, Breast (Advanced): Trastuzumab (NICE)
- Cancer, Breast (Advanced): Vinorelbine (NICE)
- Cancer, Breast (Early): Docetaxel (NICE)
- Cancer, Breast (Early): Hormonal Therapies (NICE)
- Cancer, Breast (Early): Paclitaxel (NICE)
- Cancer, Breast (Early-Stage HER2-Positive): Trastuzumab (NICE)
- Cancer, Breast (Locally Advanced or Metastatic): Capecitabine (NICE)
- Cancer, Breast (Metastatic): Gemcitabine (NICE)
- Cancer, Breast: Taxanes (NICE)
- Cancer, Colon: Capecitabine and Oxaliplatin (NICE)
- Cancer, Colorectal (Advanced): Irinotecan, Oxaliplatin and Raltitrexed (NICE)
- Cancer, Colorectal (Metastatic): Bevacizumab and Cetuximab (NICE)
- Cancer, Colorectal: Capecitabine, Tegafur and Uracil (NICE)
- Cancer, Gastro-intestinal Stromal Tumours: Imatinib (NICE)
- Cancer, Head and Neck: Cetuximab (NICE)
- Cancer, Lung (Non-Small-Cell): Pemetrexed (NICE)
- Cancer, Ovarian (Advanced): Paclitaxel, Pegylated Liposomal Doxorubicin and Topotecan (NICE)
- Cancer, Ovarian: Paclitaxel (NICE)
- Cancer, Pancreatic: Gemcitabine (NICE)
- Cancer, Prostate (Hormone-Refractory): Docetaxel (NICE)
- Cancer: Informing, Communicating and Sharing Decisions
- Cancers, Colorectal: Management of
- Cancers, Upper Gastrointestinal: Management of
- Cardiovascular Disease (CVD) Prevention: JBS Guidelines
- Cardiovascular Disease (CVD), Lipid Modification for the Prevention of (NICE)
- CFS/ME: Interventions for Management
- Coeliac Disease: Primary Care Management in Adults
- Conduct Disorders in Children, Management of (NICE)
- COPD: Management in Adults (NICE)
- Crohn's Disease: Infliximab (NICE)
- Debriding Agents and Specialist Wound Care Clinics (NICE)
- Depression and Anxiety: Computerised Cognitive Therapy (NICE)
- Depression in Primary Care: Recognition and Management of
- Depressive Disorders: Evidence-Based Guidelines
- Diabetes: Continuous Subcutaneous Insulin Infusion - Update (NICE)
- Diabetes: Long-Acting Insulin Analogues (Insulin Glargine) (NICE)
- Diabetes: Renal Disease and Self-Management
- Diabetes: Use of Glitazones (NICE)
- Diabetes: Use of Patient-Education Models (NICE)
- Drotrecogin Alfa (Activated) for Severe Sepsis (NICE)
- Eczema (Atopic), Frequency of Use of Topical Steroids (NICE)
- Eczema (Atopic): Tacrolimus and Pimecrolimus (NICE)
- Epilepsy in Adults: Newer Drugs (NICE)
- Epilepsy in Children: Newer Drugs (NICE)
- Epilepsy: Management in Women (NICE)
- Falls in Older People: Assessment and Prevention (NICE)
- Fluid Replacement Therapy in Trauma: Pre-Hospital Initiation (NICE)
- Gluten-Free Foods: A Prescribing Guide
- Growth Failure in Children: Human Growth Hormone (Somatropin) (NICE)
- Growth Hormone Deficiency in Adults: Human Growth Hormone (Somatropin) (NICE)
- H.pylori: Eradication Regimens (NICE)
- Hepatitis B, Chronic: Adefovir Dipivoxil and Peginterferon Alfa-2a (NICE)
- Hepatitis B, Chronic: Entecavir (NICE)
- Hepatitis B, Chronic: Telbivudine (NICE)
- Hepatitis C, Chronic: Interferon Alfa and Ribavirin (NICE)
- Hepatitis C, Mild Chronic: Peginterferon Alfa and Ribavirin (NICE)
- Homeopathy
- Hypercholesterolaemia, Primary: Ezetimibe (NICE)
- Hyperparathyroidism, Secondary: Cinacalcet (NICE)
- Hypertension: Management in Adults in Primary Care (NICE)
- Influenza Prophylaxis: Oseltamivir and Amantadine (NICE)
- Influenza Treatment: Zanamivir, Oseltamivir and Amantadine (NICE)
- Insomnia: Zaleplon, Zolpidem and Zopiclone (NICE)
- Juvenile Idiopathic Arthritis: Etanercept (NICE)
- Laxatives, Effectiveness in Adults
- Leukaemia, Chronic Myeloid: Imatinib (NICE)
- Lymphoma, Follicular: Rituximab (NICE)
- Macular Degeneration, Age-Related: Photodynamic Therapy (NICE)
- Macular Degeneration, Age-Related: Ranibizumab, Pegaptanib (NICE)
- Mesothelioma, Malignant Pleural: Pemetrexed (NICE)
- Motor Neurone Disease: Riluzole (Rilutek) (NICE)
- Multiple Myeloma, Relapsed: Bortezomib (NICE)
- Multiple Sclerosis, Relapsing-Remitting: Natalizumab (NICE)
- Multiple Sclerosis: Beta Interferon and Glatiramer Acetate (NICE)
- Myocardial Infarction (Acute), Use of Drugs for Early Thrombolysis (NICE)
- Myocardial Infarction: Secondary prevention (NICE)
- Nocturnal Enuresis in Children, Treatment of
- Non-Hodgkin's Lymphoma (Aggressive): Rituximab (NICE)
- Non-Hodgkin's Lymphoma, Follicular: Rituximab (NICE)
- Obesity and Overweight, Adult: Rimonabant (NICE)
- Obesity in Childhood: Prevention and Treatment
- Obesity: Management in Primary Care
- Occlusive Vascular Events: Clopidogrel and Dipyridamole (NICE)
- Opioid Dependence: Methadone and Buprenorphine (NICE)
- Opioid Dependence: Naltrexone (NICE)
- Osteoporosis: Secondary Prevention in Postmenopausal Women (NICE)
- Psoriasis in Adults: Etanercept and Efalizumab (NICE)
- Psoriasis in Adults: Infliximab (NICE)
- Psoriasis, Treatment of Adults: Adalimumab (NICE)
- Psoriatic Arthritis in Adults: Etanercept and Infliximab (NICE)
- Psoriatic Arthritis: Adalimumab (NICE)
- Renal Transplantation in Adults: Immunosuppressive Therapy (NICE)
- Renal Transplantation in Children and Adolescents: Immunosuppressive Therapy (NICE)
- Rheumatoid Arthritis: Abatacept (NICE)
- Rheumatoid Arthritis: Adalimumab, Etanercept, Infliximab (NICE)
- Rheumatoid Arthritis: Anakinra (NICE)
- Rheumatoid Arthritis: Referral and DMARD Monitoring
- Rheumatoid Arthritis: Rituximab (NICE)
- Schizophrenia: Auditing the Use of Atypical Antipsychotics (NICE)
- Schizophrenia: Newer (Atypical) Antipsychotic Drugs (NICE)
- Schizophrenia: Psychosocial Interventions
- Smoking Cessation: Nicotine Replacement Therapy and Bupropion (NICE)
- Smoking Cessation: Performing an Audit (NICE)
- Smoking Cessation: Varenicline (NICE)
- Statins for the Prevention of Cardiovascular Events (NICE)
- Stroke, Acute Ischaemic: Alteplase (NICE)
- Ulcerative Colitis, Subacute: Infliximab (NICE)
Cardiac Risk Calculator
Estimate a patient's cardiovascular risk using our simple online calculator.
MIMS Product News
Thalidomide available in the UK
Thalidomide, under the name of Thalidomide Pharmion is now commercially available in the UK. Read more
MMR catch-up programme
The DoH has written to healthcare professionals to call for urgent action to help reduce the risk of... Read more
Jobs
Job of the Week
- Locum GPs wanted North East England
- Salaried GP South East England
- Health Assessment Doctors None Specified
- GP - Australia Australasia
- Part Time Salaried GP North East England
- Salaried GP East Midlands
- GPs wanted for New Zealand Other International
- Replacement Full Time Partner and Full Time Salaried Doctor North West England
- Full Time Salaried GP Yorkshire and Humberside
- Part-time GP vacancy East of England
